Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
kidney disease
Pharma
Pfizer CEO, Otsuka, Novartis-MSN—Fierce Pharma Asia
Pfizer CEO discusses due diligence on the 3SBio deal. Otsuka details phase 3 IgAN win. Novartis pushes for a speedy Entresto ruling.
Angus Liu
Jun 13, 2025 9:18am
Travere taps Grammy-winning producer to create patient anthem
Jun 10, 2025 12:18pm
Second Novartis drug in IgAN troika crosses FDA finish line
Apr 3, 2025 10:56am
Novartis' Fabhalta nod in C3G leaves room for rival Apellis
Mar 21, 2025 10:37am
Vertex centers National Kidney Month awareness on patient story
Mar 7, 2025 9:15am
Novartis, Apellis roll out rival datasets in rare kidney disease
Oct 28, 2024 10:03am
